Biblio

Found 228 results
Author Keyword Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
Journal Article
Lee JH, Barral S, Cheng R, Chacon I, Santana V, Williamson J, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Stern Y et al..  2008.  Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.. Neurogenetics. 9(1):51-60.
Busby V, Goossens S, Nowotny P, Hamilton G, Smemo S, Harold D, Turic D, Jehu L, Myers A, Womick M et al..  2004.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.. Neuromolecular Med. 5(2):133-46.
Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR et al..  2011.  Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.. Neurobiol Aging. 32(12):2113-22.
Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR et al..  2011.  Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.. Neurobiol Aging. 32(12):2113-22.
Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR et al..  2011.  Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.. Neurobiol Aging. 32(12):2113-22.
Ridge PG, Mukherjee S, Crane PK, Kauwe JSK.  2013.  Alzheimer's disease: analyzing the missing heritability.. PLoS One. 8(11):e79771.
Karch CM, Cruchaga C, Goate AM.  2014.  Alzheimer's disease genetics: from the bench to the clinic.. Neuron. 83(1):11-26.
Karch CM, Ezerskiy LA, Bertelsen S, Goate AM.  2016.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.. PLoS One. 11(2):e0148717.
Beecham GW, Bis JC, Martin ER, Choi S-H, Destefano AL, van Duijn CM, Fornage M, Gabriel SB, Koboldt DC, Larson DE et al..  2017.  The Alzheimer's Disease Sequencing Project: Study design and sample selection.. Neurol Genet. 3(5):e194.
Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, Foroud T, Mayeux R, Shen L, Kim S, Turk M et al..  2012.  Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. PLoS One. 7(12):e50640.
van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW et al..  2004.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Kukull WA, Schellenberg GD, Bowen JD, McCormick WC, Yu CE, Teri L, Thompson JD, O'Meara ES, Larson EB.  1996.  Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.. J Clin Epidemiol. 49(10):1143-8.
Ghani M, Reitz C, Cheng R, Vardarajan BNarayan, Jun G, Sato C, Naj A, Rajbhandary R, San Wang L-, Valladares O et al..  2015.  Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.. JAMA Neurol. 72(11):1313-23.
Ghani M, Reitz C, Cheng R, Vardarajan BNarayan, Jun G, Sato C, Naj A, Rajbhandary R, San Wang L-, Valladares O et al..  2015.  Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.. JAMA Neurol. 72(11):1313-23.
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HSeng, Younkin C, Crook JE, V Pankratz S, Carrasquillo MM, Krishnan S et al..  2014.  Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.. Alzheimers Res Ther. 6(4):39.
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HSeng, Younkin C, Crook JE, V Pankratz S, Carrasquillo MM, Krishnan S et al..  2014.  Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.. Alzheimers Res Ther. 6(4):39.
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HSeng, Younkin C, Crook JE, V Pankratz S, Carrasquillo MM, Krishnan S et al..  2014.  Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.. Alzheimers Res Ther. 6(4):39.
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HSeng, Younkin C, Crook JE, V Pankratz S, Carrasquillo MM, Krishnan S et al..  2014.  Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.. Alzheimers Res Ther. 6(4):39.
Nowotny P, Hinrichs AL, Smemo S, Kauwe JSK, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P et al..  2005.  Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.. Am J Med Genet B Neuropsychiatr Genet. 136B(1):62-8.
Zou F, Chai HSeng, Younkin CS, Allen M, Crook J, V Pankratz S, Carrasquillo MM, Rowley CN, Nair AA, Middha S et al..  2012.  Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.. PLoS Genet. 8(6):e1002707.
Zou F, Chai HSeng, Younkin CS, Allen M, Crook J, V Pankratz S, Carrasquillo MM, Rowley CN, Nair AA, Middha S et al..  2012.  Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.. PLoS Genet. 8(6):e1002707.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM.  1984.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.. Neurology. 34(7):939-44.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.